Featured Partners
Partners
Defence Therapeutics granted US patent for AccuTOX® technology
Defence Therapeutics has achieved a significant milestone with the granting of US patent no. 11,890,350 ('350) by the United States Patent and Trademark Office...
BioNxt acquires cutting-edge equipment to boost drug delivery product manufacturing
BioNxt Solutions Inc. has proudly announced the acquisition of advanced coating and cutting equipment, marking a crucial stride in expanding its commercial manufacturing of...
Defence Therapeutics’ breakthrough in cancer treatment: AccuTOX® shows promise against lung tumours
Defence Therapeutics has announced the successful testing of a new formulation of its ACCUM-002TM Dimer CDCA-SV40 against lung tumours.